Translational research leads to clinical trials, which, if successful, will lead to commercialization. Meaning improved patient care, therapies, and treatments. The Department of Otolaryngology is no stranger to this success. This page tells the story of our scientists' successes and the startup companies.
Droplet Biosciences was cofounded in January 2021 by Dr. José Zevallos, Chairman of the Department of Otolaryngology and Head and Neck Cancer surgeon. This is the only liquid biopsy company founded by a surgeon.
Droplet has pioneered a platform to harvest and profile patient lymph through the routine collection of surgical drain fluid. This process will allow for earlier, more precise care following surgery, while our expansive lymph dataset will offer novel insights in areas such as patient selection and treatment response.